Related Experiment Video
Updated: Oct 12, 2025
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.4K
Irritable Bowel Syndrome and Depression: A Case Report
Joshuan Baughman1, Jacquelyn Ambrogio1, Mahfam Motevalli1
1all authors are DCN candidates at Maryland University of Integrative Health, Maryland University of Integrative Health.
Integrative Medicine (Encinitas, Calif.)
|November 22, 2021
Summary
A patient with depression and constipation-predominant irritable bowel syndrome (IBS-C) found remission through nutritional care, including diet, herbal medicine, and supplements, after conventional treatments failed.
Area of Science:
- Integrative Medicine
- Gastroenterology
- Nutritional Psychiatry
Background:
- A 26-year-old woman experienced a two-year history of depression alongside constipation-predominant irritable bowel syndrome (IBS-C), characterized by gas and bloating.
- Conventional medical evaluations diagnosed IBS-C in August 2015, but symptoms of worsening bowel irregularities and persistent depression emerged between August and November 2015.
Observation:
- The patient declined conventional therapies and sought nutritional care in November 2017.
- A comprehensive treatment plan was initiated, incorporating dietary modifications, traditional Chinese herbal medicine, and specific nutritional supplements.
Findings:
- Over a one-year period, the patient demonstrated a gradual and complete remission of both depressive symptoms and IBS-C complaints.
- This holistic approach effectively resolved the patient's gastrointestinal and mood-related issues.
Implications:
- This case highlights the potential efficacy of integrative and nutritional interventions as alternatives for managing complex conditions like IBS-C and depression.
- Further research into personalized dietary and herbal medicine strategies could offer new therapeutic avenues for functional gastrointestinal disorders and comorbid mood disturbances.
Related Concept Videos
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
381
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
381
01:17Irritable Bowel Syndrome I: Introduction
543
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
543
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
450
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
450
01:17Chronic Bowel Disorders: Introduction
565
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
565
01:17Drugs for Treatment of Diarrhea-Predominant IBS
353
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
353
01:18Depression: Overview
424
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
424